Details for New Drug Application (NDA): 071519
✉ Email this page to a colleague
NDA 071519 describes DIAZOXIDE, which is a drug marketed by Abraxis Pharm, E5 Pharma Inc, and Novitium Pharma, and is included in three NDAs. It is available from two suppliers. Additional details are available on the DIAZOXIDE profile page.
The generic ingredient in DIAZOXIDE is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
The generic ingredient in DIAZOXIDE is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
Summary for 071519
| Tradename: | DIAZOXIDE |
| Applicant: | Abraxis Pharm |
| Ingredient: | diazoxide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071519
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/ML | ||||
| Approval Date: | Aug 26, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
